Valuation (52%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 27.89 | N/A |
| PEG Ratio (TTM) | 14.78 | N/A |
| P/S Ratio (TTM) | 3.21 | N/A |
| P/B Ratio (TTM) | 4.68 | N/A |
| P/FCF Ratio (TTM) | 5.55 | N/A |
| Price to 5YR AVG Earnings Ratio | 51.64 | N/A |
| Price to 5YR AVG FCF Ratio | 3.92 | N/A |
Profitability (55%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.47% | N/A |
| ROE (TTM) | 18.13% | N/A |
| Net Profit Margin (TTM) | 11.50% | N/A |
| ROIC 5YR AVG | 26.91% | N/A |
Growth (83%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 1.96% | 13.76% | 21.64% |
| Revenue | 27.05% | 12.97% | 18.72% |
| Net Income | 2.57% | 24.78% | 31.12% |
| Cash Flow | 112.71% | 62.95% | 34.14% |
Health (37%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.12 | N/A |
| Quick Ratio (TTM) | 1.12 | N/A |
| D/E Ratio (TTM) | 0.01 | N/A |
| Interest Coverage (TTM) | 1.14 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 0.37 | N/A |
| LTL to 5YR AVG FCF | N/A | N/A |
| Shares Outstanding Growth 5YR AVG | 7.52% | N/A |